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Receptor-mediated signaling networks are very attractive
targets for the development of oncology therapeutics.
However, the complexity of these networks, characterized
by redundancy, cross-talk, and non-linearity, hinders the
generation of reliable qualitative insight into how to
develop the most effective therapeutic and deliver it to the
right patient.
We are using quantitative biochemical network models of
receptor signaling to yield significant improvements in
drug design and decision-making throughout the devel-
opment of our therapeutics. As an example, we have
developed a model of the ErbB receptor network that
includes ErbB1-4, ligand-receptor binding of different
ErbB ligands, receptor trafficking, and intracellular signal
transfer leading to ERK and Akt phosphorylation. The
model is first trained using quantitative experimental data
and then our in silico predictions are verified by an inde-
pendent set of experiments.
Using this validated biochemical network model, we
present methodologies for using local and global sensitiv-
ity analyses as in silico drug discovery tools. The applica-
tion of sensitivity analysis allows us to gain quantitative
insights into important issues including network topology
and the importance of cellular heterogeneity with respect
to protein expression. We show how these insights find
application in drug targeting and biomarker identifica-
tion.
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